Affinage

CNGB3

Cyclic nucleotide-gated channel beta-3 · UniProt Q9NQW8

Length
809 aa
Mass
92.2 kDa
Annotated
2026-06-09
44 papers in source corpus 13 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CNGB3 encodes the modulatory beta-subunit of the cone photoreceptor cyclic nucleotide-gated (CNG) channel, a retina-specific polypeptide whose mutations cause achromatopsia (ACHM3) (PMID:10958649). CNGB3 assembles with the pore-forming alpha-subunit CNGA3 into a native heterotetrameric cone CNG channel, as established by reciprocal co-immunoprecipitation and chemical cross-linking in cone-dominant retina (PMID:18665891); incorporation of CNGB3 into the channel modifies gating and pore behavior—altering apparent cAMP/cGMP affinity, single-channel conductance, and sensitivity to L-cis-diltiazem block—while null subunits leave only homomeric CNGA3-like channels (PMID:12815043). CNGB3 confers Ca2+-dependent calmodulin regulation on the channel through CaM-binding sites in both its N- and C-terminal cytoplasmic domains, since deletion of both sites abolishes Ca2+-CaM regulation that homomeric CNGA3 channels lack entirely (PMID:12730238). Beyond its electrophysiological role, CNGB3 is required for normal cone homeostasis: its loss in knockout mice selectively down-regulates CNGA3 protein and mRNA, mislocalizes cone opsins, reduces cone density, and triggers photoreceptor apoptosis and progressive cone degeneration (PMID:19767295, PMID:21273547), a phenotype reversible by AAV-mediated CNGB3 gene delivery (PMID:21576125). Most disease-associated missense mutations act as gain-of-function alleles that increase cGMP sensitivity—or, for L595F, raise ligand-independent open probability—driving calcium-entry-dependent photoreceptor cytotoxicity that can be blocked pharmacologically (PMID:16379026, PMID:23805033, PMID:26106334). A substantial fraction of pathogenic CNGB3 alleles are non-canonical splice variants that introduce pseudoexons or alter splicing (PMID:31544997, PMID:40304364).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2000 High

    Established the identity of CNGB3 as the cone CNG channel beta-subunit and linked its mutation to achromatopsia, answering what gene underlies ACHM3 on chromosome 8q21.

    Evidence cDNA cloning, Northern blot, and mutation analysis in achromatopsia families

    PMID:10958649

    Open questions at the time
    • Did not define how CNGB3 modulates channel function
    • No protein-level interaction with CNGA3 demonstrated
  2. 2002 High

    Demonstrated through canine orthologs that CNGB3 loss causes cone degeneration, validating the gene-disease relationship in a mammalian model.

    Evidence Linkage analysis and mutation sequencing in canine pedigrees (genomic deletion and D262N missense)

    PMID:12140185

    Open questions at the time
    • Did not establish the molecular channel mechanism
    • Canine-to-human functional extrapolation untested in this study
  3. 2003 High

    Defined CNGB3 as a modulatory subunit shaping channel ligand affinity, conductance, and pharmacology, and distinguished missense gain-of-function from null alleles.

    Evidence Co-expression in Xenopus oocytes, patch-clamp, and surface-expression assay of S435F and T383fs mutations

    PMID:12815043

    Open questions at the time
    • Heterologous oocyte system may not fully recapitulate native cone channel
    • Did not address in vivo consequences
  4. 2003 High

    Identified the structural basis for Ca2+-calmodulin regulation, showing CNGB3 contributes dual cytoplasmic CaM sites that the alpha-subunit alone lacks.

    Evidence Gel-overlay, GST pull-down, and domain-deletion electrophysiology in oocytes

    PMID:12730238

    Open questions at the time
    • Physiological role of CaM modulation in cones not measured in vivo
    • Stoichiometry of CaM binding in native channel unresolved
  5. 2005 High

    Correlated the magnitude of channel gain-of-function with clinical disease severity across multiple mutations, linking biophysical defect to phenotype.

    Evidence Inside-out patch-clamp of F525N, R403Q, and T383fsX heteromeric channels in oocytes

    PMID:16379026

    Open questions at the time
    • Single-lab heterologous data
    • Causal link between gain-of-function and cell death not yet demonstrated
  6. 2008 High

    Confirmed that the native cone channel is a CNGA3/CNGB3 heterotetramer through direct interaction in retinal tissue, moving beyond heterologous expression.

    Evidence Reciprocal co-IP and chemical cross-linking in Nrl-/- cone-dominant mouse retina, with NCKX2 negative control

    PMID:18665891

    Open questions at the time
    • Exact subunit stoichiometry not resolved
    • Did not address subunit assembly intermediates
  7. 2011 High

    Established the in vivo requirement of CNGB3 for cone survival, CNGA3 stabilization, and opsin localization, defining the degenerative phenotype and its developmental onset.

    Evidence ERG, qRT-PCR, Western blot, IHC, EM, and TUNEL across a developmental time-course in CNGB3-/- mice

    PMID:19767295 PMID:21273547

    Open questions at the time
    • Mechanism by which CNGB3 loss destabilizes CNGA3 not defined
    • Trigger of opsin mislocalization unresolved
  8. 2011 High

    Demonstrated that restoring CNGB3 by gene therapy rescues channel function and cone structure, providing functional proof that CNGB3 loss is the causal defect and defining a therapeutic window.

    Evidence Subretinal rAAV2/8-human-CNGB3 delivery with ERG, IHC, Western blot, and visual acuity testing in CNGB3-/- mice

    PMID:21576125

    Open questions at the time
    • Durability of rescue beyond study period untested
    • Why acuity rescue is age-limited not mechanistically explained
  9. 2013 Medium

    Provided the mechanistic link between hyperactive channel gating and photoreceptor death, showing gain-of-function mutations drive calcium-dependent cytotoxicity.

    Evidence 661W photoreceptor-derived cell death assays with CPT-cGMP, calcium removal, and L-cis-diltiazem rescue, calibrated by oocyte patch-clamp

    PMID:23805033

    Open questions at the time
    • Single-lab cell-line model rather than native cones
    • Apoptotic pathway downstream of calcium entry not detailed
  10. 2015 Medium

    Generalized the gain-of-function model across diverse macular-degeneration and achromatopsia mutations, including a ligand-independent gating mechanism, while noting exceptions.

    Evidence Inside-out patch-clamp of Y469D, L595F, P309L, G558C, and S156F heteromeric channels in oocytes

    PMID:26106334

    Open questions at the time
    • Single-lab heterologous data
    • S156F mechanism (no gain-of-function) unexplained
  11. 2025 High

    Established that a large fraction of pathogenic CNGB3 alleles are non-canonical splice variants, expanding the disease mechanism beyond coding changes and enabling variant reclassification.

    Evidence Minigene splicing assays of deep-intronic and non-canonical variants demonstrating pseudoexon insertion, exon skipping, and cryptic splice site activation

    PMID:31544997 PMID:40304364

    Open questions at the time
    • Minigene assays may not capture full endogenous splicing context
    • Quantitative impact of partial splicing defects on protein output not measured

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CNGB3 loss mechanistically destabilizes CNGA3 biosynthesis and drives opsin mislocalization, and how Ca2+-CaM modulation operates in living cones, remain unresolved.
  • No structural model of the native CNGA3/CNGB3 channel
  • Pathway coupling CNGB3 loss to CNGA3 down-regulation undefined
  • In vivo physiological role of dual CaM sites uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 4 GO:0098772 molecular function regulator activity 2
Localization
GO:0005886 plasma membrane 2 GO:0005929 cilium 1
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-1643685 Disease 3 R-HSA-9709957 Sensory Perception 3
Partners
CALM1CNGA3
Complex memberships
cone CNG channel (CNGA3/CNGB3 heterotetramer)

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 CNGB3 encodes the beta-subunit of the cone photoreceptor cGMP-gated channel; the human cDNA was cloned and shown to produce an 809 amino acid polypeptide with retina-specific expression (~4.4 kb transcript by Northern blot), and mutations in CNGB3 (missense, nonsense, frameshift, splice-site) cause achromatopsia (ACHM3) linked to chromosome 8q21. RT-PCR, RACE, Northern blot, genomic sequencing, mutation analysis in achromatopsia families Human molecular genetics High 10958649
2003 CNGB3 is a modulatory subunit that assembles with CNGA3 to form heteromeric cone CNG channels. The achromatopsia-associated S435F missense mutation in the S6 transmembrane domain increases apparent affinity for both cAMP and cGMP, decreases single-channel conductance, and reduces sensitivity to L-cis-diltiazem block, without disrupting subunit assembly or plasma membrane targeting. The null frameshift mutation T383fsΔC produces channels indistinguishable from homomeric CNGA3. Heterologous co-expression in Xenopus oocytes, patch-clamp electrophysiology, GFP-tagged subunit surface expression assay The Journal of biological chemistry High 12815043
2003 CNGB3 contains functionally important calmodulin (CaM)-binding sites in both its NH2- and COOH-terminal cytoplasmic domains. Both sites bind CaM in a Ca2+-dependent manner. Deletion of either site alone still permits Ca2+-CaM regulation of heteromeric CNGA3+CNGB3 channels, but deletion of both sites abolishes this regulation. Homomeric CNGA3 channels are not regulated by CaM. Gel-overlay assay, GST pull-down, heterologous co-expression in Xenopus oocytes, electrophysiology The Journal of biological chemistry High 12730238
2005 Three disease-associated CNGB3 mutations (F525N, R403Q, and T383fsX, including compound T383fsX/R403Q) each produce gain-of-function heteromeric cone CNG channels with increased apparent affinity for cGMP relative to wild-type, without loss of L-cis-diltiazem sensitivity (confirming heteromeric assembly). The magnitude of the gain-of-function correlated with disease severity. Heterologous co-expression in Xenopus oocytes, inside-out patch-clamp recording Molecular vision High 16379026
2008 Native cone CNG channel is a heterotetrameric complex comprising both CNGA3 and CNGB3. Co-immunoprecipitation demonstrated direct interaction between CNGA3 and CNGB3 in Nrl-/- (cone-dominant) retina. Chemical cross-linking generated products consistent with dimeric through tetrameric complexes. No association was detected between CNGA3 and the cone Na+/Ca2+-K+ exchanger NCKX2. Co-immunoprecipitation, chemical cross-linking, Western blot, immunolabeling in Nrl-/- mouse retina Journal of neurochemistry High 18665891
2009 Loss of CNGB3 in CNGB3-/- mice reduces CNGA3 protein and mRNA levels significantly (down-regulation of CNGA3 biosynthesis), impairs cone CNG channel function (photopic ERG reduced ~75%), decreases cone density (~40% reduction), and induces photoreceptor apoptosis. Rod ERG responses were unchanged. Cone-specific proteins S-opsin, Gnat2, and Pde6c mRNA were unaffected, indicating specificity of the CNGA3 effect. ERG, Western blot, quantitative RT-PCR, immunohistochemistry, TUNEL assay in CNGB3-/- mice Human molecular genetics High 19767295
2011 CNGB3 deficiency in CNGB3-/- mice causes early-onset (detectable by postnatal day 15), slowly progressive cone dysfunction and degeneration, with mislocalization of cone opsins to the outer nuclear layer and outer plexiform layer. Cone and rod synaptic marker expression and terminal ultrastructure were normal, indicating the signaling deficits arise from disrupted phototransduction rather than synaptic defects. ERG, lectin cytochemistry, Western blot, electron microscopy, immunohistochemistry in CNGB3-/- mice Investigative ophthalmology & visual science High 21273547
2011 Subretinal delivery of rAAV2/8 vector containing human CNGB3 cDNA in CNGB3-deficient mice restored CNGB3 expression in both M- and S-cones, increased CNGA3 protein levels, improved cone density and outer segment structure, normalized subcellular compartmentalization of cone opsins, and restored cone ERG amplitudes up to 90% of wild-type. Treatment was effective even at 6 months of age, but restoration of normal visual acuity required treatment at 2–4 weeks. Subretinal AAV gene delivery, ERG, immunohistochemistry, Western blot, visual acuity testing in CNGB3-/- mice Human molecular genetics High 21576125
2013 Disease-associated CNGB3 mutations F525N (gain-of-function, increased cGMP affinity) and T383fsX (null-like) increase susceptibility to cell death in photoreceptor-derived 661W cells in the presence of membrane-permeable CNG channel activator CPT-cGMP. Cytotoxicity was calcium entry-dependent and was rescued by the CNG channel blocker L-cis-diltiazem, establishing a direct link between hyperactive CNG channel gating and photoreceptor cell death. Transfection of 661W photoreceptor-derived cells, LDH cytotoxicity assay, patch-clamp in Xenopus oocytes, pharmacological block with L-cis-diltiazem and calcium removal Molecular vision Medium 23805033
2015 Multiple CNGB3 mutations associated with macular degeneration (Y469D, L595F) or complete achromatopsia (P309L, G558C) produce gain-of-function heteromeric cone CNG channels when co-expressed with CNGA3 in Xenopus oocytes, exhibiting increased ligand sensitivity or increased functional expression. L595F additionally increased spontaneous open probability in the absence of activating ligand (ligand-independent gain-of-function). S156F was the exception, not showing gain-of-function. Heterologous co-expression in Xenopus oocytes, inside-out patch-clamp recording Frontiers in physiology Medium 26106334
2019 Deep-intronic CNGB3 variants (c.1663-1205G>A and c.1663-2137C>T) cause achromatopsia by inducing pseudoexon insertion into the CNGB3 transcript, as demonstrated by heterologous splicing assays. Whole CNGB3 locus sequencing, heterologous minigene splicing assays, in silico prediction tools Human mutation High 31544997
2002 A complete genomic deletion of canine CNGB3 causes cone degeneration (cd) in Alaskan Malamutes (orthologous to human ACHM3), and a missense mutation D262N in exon 6 causes an allelic disorder in German Shorthaired Pointers, establishing the canine cd locus as orthologous to human ACHM3. Linkage analysis, genomic deletion mapping, mutation sequencing in canine pedigrees Human molecular genetics High 12140185
2025 Comprehensive functional minigene splicing assays of 21 candidate non-canonical CNGB3 variants demonstrated that 16 caused splicing defects (pseudoexon insertions, exon skipping, cryptic splice site activation), enabling reclassification of 86% of variants of uncertain significance as likely pathogenic or pathogenic. In vitro minigene splice assays, Sanger sequencing, subcloning, capillary fragment analysis The Journal of pathology High 40304364

Source papers

Stage 0 corpus · 44 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Human molecular genetics 245 10958649
2005 CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. European journal of human genetics : EJHG 203 15657609
2002 Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Human molecular genetics 152 12140185
2011 Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Human molecular genetics 144 21576125
2016 Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia. Investigative ophthalmology & visual science 98 27479814
2007 CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function. Investigative ophthalmology & visual science 77 17652762
2013 Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia. Molecular therapy : the journal of the American Society of Gene Therapy 66 23568263
2009 Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism. Human molecular genetics 65 19767295
2004 Progressive cone dystrophy associated with mutation in CNGB3. Investigative ophthalmology & visual science 63 15161866
2010 Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy. Ophthalmology 59 20079539
2017 CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients. Human mutation 54 28795510
2003 Achromatopsia-associated mutation in the human cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit alters the ligand sensitivity and pore properties of heteromeric channels. The Journal of biological chemistry 49 12815043
2007 Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. Human genetics 47 17265047
2014 CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function. Investigative ophthalmology & visual science 43 25205868
2011 Early-onset, slow progression of cone photoreceptor dysfunction and degeneration in CNG channel subunit CNGB3 deficiency. Investigative ophthalmology & visual science 41 21273547
2003 Functionally important calmodulin-binding sites in both NH2- and COOH-terminal regions of the cone photoreceptor cyclic nucleotide-gated channel CNGB3 subunit. The Journal of biological chemistry 41 12730238
2023 First-in-Human Gene Therapy Trial of AAV8-hCARp.hCNGB3 in Adults and Children With CNGB3-associated Achromatopsia. American journal of ophthalmology 36 37172884
2008 Native cone photoreceptor cyclic nucleotide-gated channel is a heterotetrameric complex comprising both CNGA3 and CNGB3: a study using the cone-dominant retina of Nrl-/- mice. Journal of neurochemistry 34 18665891
2019 Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation. Human mutation 32 31544997
2017 Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs. Human gene therapy. Clinical development 26 29020838
2016 Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. Human gene therapy. Clinical development 25 27003752
2005 Disease-associated mutations in CNGB3 produce gain of function alterations in cone cyclic nucleotide-gated channels. Molecular vision 25 16379026
2013 Genomic deletion of CNGB3 is identical by descent in multiple canine breeds and causes achromatopsia. BMC genetics 24 23601474
2010 Novel CNGA3 and CNGB3 mutations in two Pakistani families with achromatopsia. Molecular vision 18 20454696
2020 Generation of Nonhuman Primate Model of Cone Dysfunction through In Situ AAV-Mediated CNGB3 Ablation. Molecular therapy. Methods & clinical development 14 32953936
2015 Intravitreal Ciliary Neurotrophic Factor Transiently Improves Cone-Mediated Function in a CNGB3-/- Mouse Model of Achromatopsia. Investigative ophthalmology & visual science 12 26567794
2015 Inherited macular degeneration-associated mutations in CNGB3 increase the ligand sensitivity and spontaneous open probability of cone cyclic nucleotide-gated channels. Frontiers in physiology 11 26106334
2004 [Molecular genetic findings in patients with congenital cone dysfunction. Mutations in the CNGA3, CNGB3, or GNAT2 genes]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 11 15459792
2021 Disease Progression in CNGA3 and CNGB3 Retinopathy; Characteristics of Slovenian Cohort and Proposed OCT Staging Based on Pooled Data from 126 Patients from 7 Studies. Current issues in molecular biology 10 34449556
2020 Intraobserver Repeatability and Interobserver Reproducibility of Foveal Cone Density Measurements in CNGA3- and CNGB3-Associated Achromatopsia. Translational vision science & technology 9 32832242
2017 Whole exome sequencing unveils a frameshift mutation in CNGB3 for cone dystrophy: A case report of an Indian family. Medicine 8 28746191
2013 Disease-associated mutations in CNGB3 promote cytotoxicity in photoreceptor-derived cells. Molecular vision 8 23805033
2019 AAV-mediated human CNGB3 restores cone function in an all-cone mouse model of CNGB3 achromatopsia. Journal of biomedical research 5 32305965
2018 A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3. Investigative ophthalmology & visual science 5 30592498
2014 Five novel CNGB3 gene mutations in Polish patients with achromatopsia. Molecular vision 5 25558176
2023 Molecular and Clinical Characterization of CNGA3 and CNGB3 Genes in Brazilian Patients Affected with Achromatopsia. Genes 4 37372476
2021 A deep intronic substitution in CNGB3 is one of the major causes of achromatopsia among Jewish patients. Molecular vision 4 34703197
2021 CNGB3 Missense Variant Causes Recessive Achromatopsia in Original Braunvieh Cattle. International journal of molecular sciences 4 34830323
2024 fMRI and gene therapy in adults with CNGB3 mutation. Brain research bulletin 3 38971478
2025 Comprehensive functional splicing analysis of non-canonical CNGB3 variants using in vitro minigene splice assays. The Journal of pathology 2 40304364
2014 Spectral domain optical coherence tomography findings in CNGB3-associated achromatopsia and therapeutic implications. Advances in experimental medicine and biology 2 24664743
2023 Absent meibomian glands and cone dystrophy in ADULT syndrome: identification by whole exome sequencing of pathogenic variants in two causal genes TP63 and CNGB3. Ophthalmic genetics 1 37158316
2020 Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes. International ophthalmology 1 32869108
2025 Pathogenic Deep Intronic Variant in CNGB3 Identified From Whole-Genome Sequencing in an Unsolved Case of Patient Affected With Achromatopsia. Case reports in genetics 0 40463445

Missed literature

Know a paper Affinage missed for CNGB3? Flag it for the maintainers and the community.

No submissions yet.